Dr. Rispah Torrorey-Sawe is lecturer of Immunology in the School of Medicine, Colleges of Health Sciences, Moi University. She obtained her B.Ed science and MSc in Immunology between the year 2003 and 2007 at Moi Unversity. Her Ph.D. research on characterizing breast cancer into molecular subtypes in relation to tumor infiltrating leucocytes has added up to the knowledge necessary for developing immunotherapy for breast cancer in the African population. She did her post-doctoral training research in the field of personalized genomic medicine at the Division of Chemical Pathology Stellenbosch University, Tygerberg campus. Her current project, aims to combine genetic testing through Next generation Sequencing (NGS) of high-risk patients with familial breast cancer with pharmacogenetics to reduce recurrence risk in cancer survivors due to drug failure as a consequence of anti-cancer treatment that does not match the patient's genotype.